BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29330786)

  • 1. Kinetic Analysis of HIF Prolyl Hydroxylases.
    Koivunen P; Myllyharju J
    Methods Mol Biol; 2018; 1742():15-25. PubMed ID: 29330786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Many amino acid substitutions in a hypoxia-inducible transcription factor (HIF)-1alpha-like peptide cause only minor changes in its hydroxylation by the HIF prolyl 4-hydroxylases: substitution of 3,4-dehydroproline or azetidine-2-carboxylic acid for the proline leads to a high rate of uncoupled 2-oxoglutarate decarboxylation.
    Li D; Hirsilä M; Koivunen P; Brenner MC; Xu L; Yang C; Kivirikko KI; Myllyharju J
    J Biol Chem; 2004 Dec; 279(53):55051-9. PubMed ID: 15485863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of a viral prolyl hydroxylase.
    Langley GW; Abboud MI; Lohans CT; Schofield CJ
    Bioorg Med Chem; 2019 Jun; 27(12):2405-2412. PubMed ID: 30737136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
    Flashman E; Davies SL; Yeoh KK; Schofield CJ
    Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a robust enzymatic assay for inhibitors of 2-oxoglutarate-dependent hydroxylases.
    Kanelakis KC; Palomino HL; Li L; Wu J; Yan W; Rosen MD; Rizzolio MC; Trivedi M; Morton MF; Yang Y; Venkatesan H; Rabinowitz MH; Shankley NP; Barrett TD
    J Biomol Screen; 2009 Jul; 14(6):627-35. PubMed ID: 19498081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate preference of the HIF-prolyl hydroxylase-2 (PHD2) and substrate-induced conformational change.
    Pektas S; Knapp MJ
    J Inorg Biochem; 2013 Sep; 126():55-60. PubMed ID: 23787140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a colorimetric α-ketoglutarate detection assay for prolyl hydroxylase domain (PHD) proteins.
    Wong SJ; Ringel AE; Yuan W; Paulo JA; Yoon H; Currie MA; Haigis MC
    J Biol Chem; 2021; 296():100397. PubMed ID: 33571527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor.
    Hirsilä M; Koivunen P; Günzler V; Kivirikko KI; Myllyharju J
    J Biol Chem; 2003 Aug; 278(33):30772-80. PubMed ID: 12788921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Hippel-Lindau β-domain-luciferase fusion protein as a bioluminescent hydroxyproline sensor for a hypoxia-inducible factor prolyl hydroxylase assay.
    Hong S; Yum S; Ha NC; Jung Y
    Anal Biochem; 2010 Dec; 407(2):220-5. PubMed ID: 20705044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha.
    Koivunen P; Tiainen P; Hyvärinen J; Williams KE; Sormunen R; Klaus SJ; Kivirikko KI; Myllyharju J
    J Biol Chem; 2007 Oct; 282(42):30544-52. PubMed ID: 17726031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2.
    Abboud MI; McAllister TE; Leung IKH; Chowdhury R; Jorgensen C; Domene C; Mecinović J; Lippl K; Hancock RL; Hopkinson RJ; Kawamura A; Claridge TDW; Schofield CJ
    Chem Commun (Camb); 2018 Mar; 54(25):3130-3133. PubMed ID: 29522057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a second Arabidopsis thaliana prolyl 4-hydroxylase with distinct substrate specificity.
    Tiainen P; Myllyharju J; Koivunen P
    J Biol Chem; 2005 Jan; 280(2):1142-8. PubMed ID: 15528200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases.
    Chowdhury R; Leung IK; Tian YM; Abboud MI; Ge W; Domene C; Cantrelle FX; Landrieu I; Hardy AP; Pugh CW; Ratcliffe PJ; Claridge TD; Schofield CJ
    Nat Commun; 2016 Aug; 7():12673. PubMed ID: 27561929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
    Mole DR; Schlemminger I; McNeill LA; Hewitson KS; Pugh CW; Ratcliffe PJ; Schofield CJ
    Bioorg Med Chem Lett; 2003 Aug; 13(16):2677-80. PubMed ID: 12873492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors.
    Thirstrup K; Christensen S; Møller HA; Ritzén A; Bergström AL; Sager TN; Jensen HS
    Pharmacol Res; 2011 Sep; 64(3):268-73. PubMed ID: 21504793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway.
    Hirsilä M; Koivunen P; Xu L; Seeley T; Kivirikko KI; Myllyharju J
    FASEB J; 2005 Aug; 19(10):1308-10. PubMed ID: 15941769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human oxygen sensing may have origins in prokaryotic elongation factor Tu prolyl-hydroxylation.
    Scotti JS; Leung IK; Ge W; Bentley MA; Paps J; Kramer HB; Lee J; Aik W; Choi H; Paulsen SM; Bowman LA; Loik ND; Horita S; Ho CH; Kershaw NJ; Tang CM; Claridge TD; Preston GM; McDonough MA; Schofield CJ
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13331-6. PubMed ID: 25197067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolyl 4-hydroxylases, key enzymes in the synthesis of collagens and regulation of the response to hypoxia, and their roles as treatment targets.
    Myllyharju J
    Ann Med; 2008; 40(6):402-17. PubMed ID: 19160570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity.
    Jeong S; Park H; Hong S; Yum S; Kim W; Jung Y
    Eur J Pharmacol; 2015 Jan; 747():114-22. PubMed ID: 25483211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism.
    Tapio J; Halmetoja R; Dimova EY; Mäki JM; Laitala A; Walkinshaw G; Myllyharju J; Serpi R; Koivunen P
    J Biol Chem; 2022 Aug; 298(8):102222. PubMed ID: 35787374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.